Researchers at the University of California, Los Angeles (UCLA) have pioneered a groundbreaking approach in the imaging and ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

In a major discovery, scientists have presented the first evidence of Alzheimer's disease transmission in living individuals.

Increasingly, researchers are looking to develop blood tests that could help make Alzheimer's diagnosis faster, more accurate ...

Despite enormous effort, disease-modifying therapies for Alzheimer's disease, the most common cause of dementia, have proven ...

Colorado researcher Huntington Potter discusses a clinical trial to see whether the drug Leukine, normally used for bone ...

Professor Marianna Fontana, of University College London (UCL) and Royal Free Hospital, said: “ATTR is a progressive, fatal ...

Another discounted factor why women are more prone to developing Alzheimer’s is that on an average, they live longer than men ...

Vutrisiran significantly improved mortality, cardiovascular events and markers of disease progression in patients with ...

T-Neuro Pharma, a leading biotechnology research company dedicated to developing innovative therapies for neurodegenerative ...

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the ...

The future of CRISPR involves clinical trials focused on treatment for blood diseases and cancers, cardiovascular disease, ...